Tiotropium add-on therapy is safe and reduces seasonal worsening in paediatric asthma patients

There remains an unmet need for effective, well-tolerated therapeutic options in paediatric patients with not fully controlled asthma, for whom safety is of paramount importance. Data were pooled from five randomised, double-blind, placebo-controlled studies evaluating tiotropium 5 or 2.5 µg versus...

Descripción completa

Detalles Bibliográficos
Autores principales: Vogelberg, Christian, Szefler, Stanley J., Vrijlandt, Elianne J.L.E., Boner, Attilio L., Engel, Michael, El Azzi, Georges, Vulcu, Sebastian Dan, Moroni-Zentgraf, Petra M., Eickmeier, Olaf, Hamelmann, Eckard H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581158/
https://www.ncbi.nlm.nih.gov/pubmed/31097514
http://dx.doi.org/10.1183/13993003.01824-2018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581158/
https://www.ncbi.nlm.nih.gov/pubmed/31097514
http://dx.doi.org/10.1183/13993003.01824-2018

Ejemplares similares